Pre-Purchase Touchpoints: Predictable Encounters, Unknowable Results In this three-part post, we explore the stages of the customer-supplier experience and touch on the most significant determinants of Brand success. For a full report of the pre-purchase, product-usage and post-purchase customer experience, check out our latest report, Enhancing the Customer Experience: Insights and Life Science Supplier Rankings. […]
A citizen of Bangalore, India from the mid-20th century would hardly recognize the city today. The Indian metropolis, once sparsely littered with office buildings and palm trees amid crooked streets, is today dominated by skyscrapers, highways, and Starbucks coffee shops. Since the establishment of the first multinational corporation (Texas Instruments in 1985) this eastern Silicon […]
Since the Doudna and Charpentier labs first realized the gene-editing capabilities of the CRISPR/Cas9 system, the field expanded outward until it could be found in every corner of biological research. Whether it’s discovering oncogenes, tracking chromosomal recombination, building gRNA libraries, or identifying protein-binding domains for drug development, the versatility of CRISPR/Cas9 continues to captivate the […]
Every day, mankind creates 2.5 quintillion bytes of data. The rate of our data production is so great that 90% of the world’s data today was created in the last two years alone. This information flows from many sources; climate sensors, investing algorithms, music videos and social media posts all contribute to the formation of […]
On November 18th, 2015, Germany’s Merck KGaA announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. This month, we invited over 300 global customers of both companies and asked for their reaction to the mega merger. We invite you to download our complimentary report and discover customer sentiments, […]
BioInformatics has become the preeminent leader in the market for commercial and VOC data, analysis and industry-wide opinions about the hottest topic in the life sciences: CRISPR/Cas9 technology. (See our complimentary report The CRISPR Toolbox.) In the 2016 Life Science Global Lab Funding & Budget Outlook, we polled members of The Science Advisory Board and asked: “What do […]
There’s probably no better way to predict the future of science than to crowdsource opinions from hundreds of global scientific researchers. So, that’s what we did! In the 2016 Life Science Global Lab Funding & Budget Outlook, we polled members of The Science Advisory Board and asked: “What do you think is the most exciting technological […]
Following our latest publication, The 2016 Market for CRISPR/Cas9 Genome Editing Products, released in June 2015 on the Interactive Market Intelligence platform, a follow-up questionnaire was sent to The Science Advisory Board to quantify how the emergence of CRISPR/Cas9 technology is impacting the use of traditional tools and techniques. The questionnaire was fielded between July […]
Diving into Part II of the CRISPR Workflow series, we are exploring how our panel believes feel that current tools, techniques and methods will be impacted due to the emergence of CRISPR technology in their labs. We know that while many of our clients are seeking preeminence in newly formed product lines for CRISPR/Cas9 kits and consumables, the […]
Following the insights gained from our The Market for CRISPR/Cas9 Genome Editing Products report (released June 2015 on the Interactive Market Intelligence platform), we fielded a follow-up questionnaire to our expert panel to quantify how the emergence of CRISPR is impacting the use of traditional tools and techniques. The following insights are Part One of a series […]
